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Insulin analogues labelled with stable isotopes (e.g. deuterium,
18O, 15N, etc.) are authentic (the native structure is
rigorously maintained), non-radioactive (preferred for
injection into man) and can easily be distinguished from
endogenous insulin by mass spectrometry by virtue of their
molecular masses. Appropriate combinations of amino-
protecting groups (methylsulphonylethyloxycarbonyl and t-
butoxy carbonyl), Edman degradation and chemical coupling
were used to produce [octadeutero-Phe^J-porcine insulin
and [octadeutero-PheB1-octadeutero-ValB2]-porcine insulin.
The analogues were characterized by electrospray ionization
mass spectrometry. Standard mixtures of labelled and
unlabelled insulins were successfully studied by mass
spectrometry. Isotope dilution mass spectrometry could
therefore provide a useful direct measure of insulin under
true physiological conditions, without many of the drawbacks
of existing methods. In this regard, the analogue with 16
deuteriums was more suitable than the octadeuterated
analogue, since the greater mass difference between the
labelled and unlabelled forms enabled a lower mass
spectrometric resolution to be used, resulting in higher
sensitivity.
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Introduction
Studies of insulin metabolism in man have relied very heavily
on the use of radioiodinated insulin (Hamlin and Arquilla, 1974;
Stentz et al., 1982). Such derivatives present the disadvantages,
in addition to their radioactivity, that they may change the
behaviour of the molecule under certain circumstances (Sodoyez
et al., 1973), although some authors (e.g. Freychet et al., 1971;
Glieman et al., 1979) have found no loss in biological activity.
Semisynthetic methods (Offbrd, 1980) have allowed the
production of a variety of isotopically substituted insulin
analogues which have been used for pharmacokinetic and
mechanistic studies, mainly in vitro or in vivo in animals. These
analogues, usually carrying a tritium label, have the advantage
over iodinated insulin derivatives that their native structure and
biological activities are rigorously maintained. Halban and Offord
(1975) produced a semisynthetic tritiated insulin by specifically
replacing Phe81 with a tritiated phenylalanine. Davies and
Offord (1985) synthesized tritiated insulin specifically labelled
at GlyA1. Specific labelling of other sites with 13C (Saunders and
Offord, 1972), deuterium (on Tyr*14, Savoy et al., 1988) or 18O
(on Lys329, Markussen etal, 1983; Rose etal., 1984) have
also been achieved. Labelling with isotopes of oxygen and
hydrogen has permitted, for example, the elucidation of the
mechanistic process of trypsin-catalysed semisynthesis of human
insulin by fast atom bombardment mass spectrometry (Rose
et al., 1991) or the measurement of steady-state turnover and
metabolic clearance of insulin in dogs (Morishima et al., 1985).
The biosynthesis of specifically tritiated insulin could be achieved
using in vitro cultures of rat pancreatic islet cells grown in a
medium containing tritiated phenylalanine or isoleucine (Misbin
etal., 1981).
In order to pursue our pharmacokinetic studies in man, we have
chosen to develop an analytical method based on isotope dilution
mass spectrometry. To this end, we have synthesized and
characterized two new analogues of porcine insulin and
demonstrate that they can be used as internal standards for the
quantitation of insulin.
Materials and methods
Reagents and solvents
Porcine insulin (monocomponent grade, zinc form) was
purchased from Novo Industri, Denmark. Octadeutero-L-
phenylalanine and octadeutero-L-valine (99 at.% deuterium,
unlabile protons) were obtained from Cambridge Isotope
Laboratories. Water was purified on a milli-Q system (Millipore).
Dimethylformamide (DMF) and Af-ethylmorpholine were purified
as described by Halban and Offord (1975). Pyridine was
redistilled at atmospheric pressure (b.p. 110°C). Phenylisothio-
cyanate (PITC, sequence analysis grade; Fluka) was redistilled
under reduced pressure widi a nitrogen bleed at 48—50°C. Urea
was made up as an 8 M solution and passed through a column
of Amberlite MB3 resin (BDH) immediately before use. Diemyl
ether was dried over sodium metal and then passed through a
glass column containing fresh, dry aluminium oxide 90 (active,
neutral, 70-230 mesh ASTM, class I; Merck), the first two
column volumes of solvent being discarded. All reactions took
place in hermetically sealed tubes. All other reagents and solvents
were of analytical grade or better, were obtained from com-
mercial sources and were used without further purification unless
otherwise stated.
Mass spectrometry
Mass spectrometric analyses of the title compound were carried
out on a VG-Trio 2000 instrument fitted with a 3000 a.m.u. RF
generator (VG Biotech, Manchester, UK). The mass spectrometer
was equipped with an electrospray ion source (ESI-MS) and
operated in positive ionisation mode under control of the Lab-
Base data system. A mass spectrometric resolution of ~500 and
a scan rate of 10 s from mlz 800 to 1500 were generally used.
Data were processed using a six-point smoothing routine.
Quantitative analyses of [octadeutero-Phe^-insulin were carried
out on a Bio-Q instrument (VG Biotech). Aliquots (10 yl) were
injected at a flow rate of 5 /tl/min. The quadrupole was scanned
at 11 s/scan cycle from mlz 1140 to 1180 to cover the insulin
peaks carrying five charges. A 13-point smoothing routine was
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used to process the data. The quadrupole resolution was adjusted
to approach as nearly as possible the theoretical resolution set
by the isotope distribution, without sacrificing too much
sensitivity. External calibration of the mass scale was performed
with a solution of horse myoglobin (Sigma).
Reversed phase HPLC
Analytical HPLC was performed with the same equipment,
column and solvents as described by Rose et al. (1991). For
purification steps, HPLC was performed using equipment from
Waters Associates consisting of two M-45 pumps, a model 720
system controller and a model 440 absorbance detector with a
prior pass through an extended wavelength module (229 nm).
The column was 250 x 10 mm diameter packed with Nucleosil
C|8 7 /tm 300 A particles (Macherey Nagel) and operated at a
flow rate of 4 ml/min. Solvent A was 100 ml 3 M (NH^SCv
adjusted to an apparent pH of 2.7 (glass electrode) with
concentrated sulphuric acid prior to making up to 1 1 with water.
Solvent B was 100 ml 3 M (NHt^SO,,, adjusted to pH 2.7 with
concentrated sulphuric acid prior to addition of 350 ml acetonitrile
and making up to 1 1 with water.
Preparation, purification and activation of t-butoxycarbonyl
(BOC)-octadeutero-valine
Octadeutero-valine (16.07 mg, 150 /unol) was dissolved in 1 ml
water, 1 ml DMF and 25 /tl N-ethylmorpholine were added. The
pH was found to be between 8 and 9 with paper pH indicator
strips (0-14 range; Merck) previously moistened with water.
Di-f-butyl dicarbonate (202.5 /tl) was added at room temperature
and the reaction was stirred for 20 h at room temperature. The
reaction was followed by thin layer chromatography (TLC, silica
60), as described by Davies and Offord (1985) for BOC-glycine,
and found to be complete on ninhydrin and HCl/ninhydrin
staining. The product was vacuum-dried, resuspended in 1 ml
50 mM HC1 and extracted six times with 2 ml ethyl acetate. The
extraction efficiency was checked using the same TLC system.
The six fractions of ethyl acetate were pooled, evaporated to
dryness and the product stored at -20°C until required for
activation.
The residue was then dissolved in 1 ml DMF and N-
hydroxysuccinimide (20.4 mg, 100 /unol in 1 ml DMF) and
/V,/V-dicyclohexylcarbodiimide (DCC, 11.52 mg, 100 /imol in
1 ml DMF) were added to it. The reaction was left at room
temperature for 5 h, with stirring every 30 min, and the formation
of a white precipitate (dicyclohexyl urea) was observed. The tube
was centrifuged for 2 min in a bench centrifuge and only the
supernatant was used. The activation reaction was followed by
TLC on silica gel (Kohn and Wilchek, 1982) using
chloroform/methanol (9:1 v/v) as solvent (1 /il reaction mixture
and 1 /tl DCC at the same concentration were spotted on a TLC
plate). After migration, the plate was sprayed with a solution
containing 0.5 g N./V-dimethylbarbituric acid in 10 ml
pyridine/water (9:1 v/v). No remaining DCC was detectable.
Preparation, purification and activation of methylsulphonylethyl-
oxycarbonyl (MSC)-octadeutero-phenylalanine
Octadeutero-phenylalanine (100 mg) was slowly disolved in 3 ml
dimethylsulphoxide (DMSO), and 100 /il N-ethylmorpholine
were added to obtain a pH of 8.8. Methylsulphonylethyloxy-
carbonyl-N-hydroxysuccinimide ester (350 mg, 2 Eq) was added
and the solution was stirred at room temperature. The reaction
was followed by electrophoresis on paper at pH 6.5, as described
by Davies and Offord (1985), and found to be quantitative after
1 h. Acetic acid (100 /tl) and 0.1% (w/v) trifluoroacetic acid
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(TFA) (50 ml) were added to the mixture and the product was
purified on Sep-Pak-C18 cartridges (Waters Associates, Milford,
MA, USA). After washing the cartridge with methanol (10 ml)
and then 0.1% TFA (10 ml), 8 ml portions of the reaction
mixture were loaded, 10 ml 0.1 % TFA were used to wash the
cartridge and the product was eluted in 4 ml 50% acetonitrile
containing 0.1% TFA. After washing with 80% acetonitrile
(10 ml) and re-equilibration of the cartridge with 0.1% TFA
(10 ml), the loading and purification process was repeated seven
times and the fractions of purified product were pooled,
evaporated under a stream of nitrogen and freeze-dried. A white
powder was obtained and stored at — 20°C.
A part of the product (9.15 mg, 30 /imol) was dissolved in
500 /tl DMF and N-hydroxysuccinimide (2.88 mg, 25 /tmol, in
250 /tl DMF) and DCC (5.16 mg, 25 /tmol, in 250 /tl DMF)
were added. The activation reaction was left for 20 h at room
temperature. Although no urea precipitated, the TLC test snowed
no trace of DCC in the reaction.
Preparation and purification of [des-Ph^'-Val82, AJ-B29-di-
MSC]-porcine insulin
[Al-B29-di-MSC]-porcine insulin was prepared as previously
described (Offord, 1980, p. 43), using 250 mg insulin as starting
material. After 20 h of reaction under constant stirring, the
product was precipitated with ice-cold dried diethyl ether (4 vol),
washed three times with ether and carefully dried under reduced
pressure. The product was analysed by electrophoresis on
cellulose acetate, as previously described (Rose et al., 1981),
and purified by anion exchange chromatography on Sephadex
A25, as described by Offord (1980, p. 44). The fractions of the
main peak were pooled and desalted in seven portions on a Sep-
Pak cartridge, washing with 10 ml 0.1 % TFA and eluting with
4 ml 80% acetonitrile containing 0.1 % TFA. The eluates were
evaporated under a stream of nitrogen, pooled and freeze-dried
overnight.
The product was then dissolved at 10 mg/ml in 8 M urea and
purified stepwise by reversed-phase HPLC using the preparative
system described above: 71 % solvent B was found to be excellent
for isocratic purification of the product. The acetonitrile present
in the collection tubes was evaporated under a nitrogen flow and
the product was desalted using a Sep-Pak cartridge, as above.
A yield of 56.1 mg of pure [Al-B29-di-MSC]-porcine insulin
was obtained. A sample was submitted for analysis on an
automated amino acid sequence analyser (Applied Biosy stems
477 A).
A 25 mg/ml solution of the insulin derivative in pyridine/water
(95:5 v/v) was prepared (2.25 ml) and 8.6 /tl PITC were added
(7.4 molar Eq). The reaction was left for 4 h at room temperature
under constant stirring. The product was then precipitated and
further washed three times with 8 ml dried ether, as previously
described, and carefully dried under vacuum to give 50.1 mg
of product. This was dissolved at 14 mg/ml in anhydrous TFA
and left for 1 h at room temperature, being stirred for 15 s every
10 min. The volume was then reduced to less than 0.5 ml under
a stream of filtered air. The protein was then precipitated with
8 ml ether, washed three times with 8 ml portions of ether and
dried as above. A yield of 46.3 mg of [des-PheBl, Al-B29-di-
MSC]-porcine insulin was obtained. A sample was purified by
HPLC (analytical system) and examined by electrospray mass
spectrometry.
The product (23 mg) was submitted to a second Edman
degradation cycle, following the same procedure as described
above, and 22 mg of dried [des-Phem-Waim, Al-B29-di-
MSC]-porcine insulin were obtained and purified by HPLC under
Phe-Vol-
Msc
Phc-Val
Msc
Val
Msc
Msc-
Val-d,-
Msc-
Msc-Phe-dj-Val-d,-
Phe-d.-Vol-d,-
z
MscOSu
- Lys-AIn
NH2
/
| 0 P,TC
V ii) TFA
/
Msc
1 i) PITC
V n) TFA
/
0 Boc-Val-djOSu
ii)TFA
Msc
Z
J , Msc-Phe-djOSu
Msc
Msc
NaOH
z
(I)
(II)
(Til)
(IV)
(V)
(VI)
(VII)
NH,
Fig. 1. Semisynthesis of [octadeutero-PheB1-cxaadeutero-ValB2]-porcine
insulin. (I) Porcine insulin; (U) [Al-B29-di-MSC]-insulin; (HI) [des-Phe81,
Al-B29-di-MSC]-insulin; (TV) [dtr-Ph^'-Val82, Al-B29-di-MSC]-insulin;
(V) [dej-Phe81, octadeutero-ValK, Al-B29-di-MSC]-insulin; (VI) [MSC-
octadeutero-Ph^'-octadeutero-Val^, Al-B29-di-MSC]-insulin; (VII)
[octadeutero-Ph^'-octadeutero-Val ]-porcine insulin.
Deuterated insulin: semisynthesis and mass spectrometry data
the preparative conditions as previously described. The product
was examined by ESI-MS.
Synthesis and purification of [octadeuterv-Phe81-octadeutero-
ValB2]-porcine insulin
To 8 mg of [des-PheB'-Val82, Al-B29-di-MSC]-porcine insulin,
dissolved at 12 mg/ml in DMF, were added 2.7 ml freshly
prepared BOC-octadeutero-Val hydroxy succinimide ester and
377 ii\ hydroxybenzotriazole (12 mg/ml) in DMF (0.67 mol
hydroxybenzotriazole per mol active ester). /V-ethylmorpholine
(70 /tl) was added to bring the apparent pH to a value between
8 and 9 as determined by paper pH indicator strips. The reaction
was left for 21 h at room temperature and the pH was found
still to be between 8 and 9. The product was then precipitated,
washed three times with 8 ml portions of dried ether and vacuum-
dried. The protein was then dissolved at 12 mg/ml in anhydrous
TFA and left under stirring for 1 h at room temperature to remove
the BOC protecting group on the octadeutero-valine in the B2
position. The volume was then reduced to less than 300 /xl under
a nitrogen flow and the insulin analogue precipitated and washed
with ether, as above.
A portion of the residue (7.5 mg) was dissolved in 600 jd DMF
and the preparation of 25 /tmol activated MSC-octadeutero-
phenylalanine added, followed by 166 /il hydroxybenzotriazole
and 50 /tl AZ-ethylmorpholine. The apparent pH was again
between 8 and 9 and the reaction was set aside for 18 h at room
temperature. The alkaline deprotection of the three MSC groups
was carried out as described by Davies and Offord (1985) and
the final product was purified on HPLC and examined by
ESI-MS.
Synthesis and purification of \octadeutero-PheBI'\-porcinc insulin
A portion (1.2 mg) of the [des-Phe?\ Al-B29-di-MSC]-porcine
insulin was used in a coupling with activated octadeutero-Phe,
similar to the one described above [bypassing steps (TV) and (V)
of Figure 1]. The product was purified by HPLC and examined
by ESI-MS.
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Fig. 2. Mass spectrum of the hexadecadeuterated analogue of porcine insulin (Vn). [Octadeutero-Ph^'-octadeutero-Val^l-porcine insulin. The measured
molecular mass is 5792.8 and the calculated mass is 5793.7. The raw data have been processed using a 13-point smoothing routine. The mass spectrum shows
three peaks on the mass to charge (m/z) scale, corresponding to the same molecule carrying different charges (z) due to 6. 5 and 4 protons.
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